Professionals in creative industries should have some form of protection against others exploiting what they have created, ...

All this screen time isn’t just negatively affecting our sleep, but also taking a toll on our skin quality by increasing our ...

Cash and Cash Equivalents: As of September 30, 2025, Kymera had $978.7 million in cash, cash equivalents and investments. Kymera expects that its cash balance will provide the Company with a cash ...

Q3 2025 Earnings Call Transcript October 30, 2025 Phathom Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Viking Therapeutics, Inc. progressing rapidly with its Phase 3 VANQUISH trials of VK2735 set to complete enrolment. Learn ...

Combined revenues of the Company's four growth products increased 52% to $149.2 million in the third quarter of 2025, compared to the same period ...

Meets or exceeds all third quarter guidance metrics GAAP Net income of $5.2 million reflects $35 million year-over-year improvement GAAP EPS of $0.11, up $0.86 versus prior-year period Adjusted EPS of ...

PepGen shifts focus to PGN-EDODM1 for Myotonic Dystrophy Type 1 after discontinuing PGN-EDO51 for Duchenne Muscular Dystrophy ...

Zomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter! ANN ARBOR, MI / ACCESS Newswire / November 4, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" ...

Stacker compiled a list of the best counties to live in New York.

Q3 2025 Earnings Call Transcript November 3, 2025 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS ...

CNW/ - Canadian physicians cite administrative burden as one of the leading causes of stress and burnout1. While much of the ...